search
Back to results

Peritoneum Vaginoplasty; Implementation According to IDEAL Framework (PeriVaS)

Primary Purpose

Rokitansky Kuster Hauser Syndrome, Vaginal Neoplasms, Gender Incongruence

Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Laparoscopic pedicled single flap peritoneum vaginoplasty
Sponsored by
Amsterdam UMC, location VUmc
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Rokitansky Kuster Hauser Syndrome

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Indication for vaginoplasty, with no option to use penoscrotal tissue or with shortage of penoscrotal tissue. Age >18 Able to give informed consent Exclusion Criteria: Contra-indication for laparoscopic surgery Smoking (cessation for at least 6 weeks) BMI 18 < or >30 kg/m2

Sites / Locations

  • Amsterdam University Medical CenterRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

intervention

Arm Description

All participants will undergo a laparoscopic single flap peritoneum vaginoplasty

Outcomes

Primary Outcome Measures

90 day postoperative complications. Reported by full description of the event and eventual treatment and classified according to Clavien-Dindo classification.
Reported by full description of the event and eventual treatment and classified according to Clavien-Dindo classification.

Secondary Outcome Measures

Successful technical completion of operation
Postoperative dimension of the neovagina of at least 12 cm, measured by a measuring dilatator.
Operation time
Learning curve of surgeons
Blood loss
Total estimated blood loss during operation by surgeon in ml
Length of hospital stay
The total amount of days spend in the hospital after operation up until discharge.
Sexual function
Sexual function measured by the sexual function form of the genderQ
Urinary function
Urinary function measured by the urinary function form of the genderQ
Post-operative pain
Postoperative pain reported by patient either none-normal-or excessive
Neovaginal dimensions
Postoperative dimension of the neovagina, measured by a measuring dilatator.
Clitoral sensation
patient assessed outcome, either none- less- normal or hyper

Full Information

First Posted
February 7, 2022
Last Updated
June 28, 2023
Sponsor
Amsterdam UMC, location VUmc
search

1. Study Identification

Unique Protocol Identification Number
NCT05925361
Brief Title
Peritoneum Vaginoplasty; Implementation According to IDEAL Framework
Acronym
PeriVaS
Official Title
Pedicled Peritoneum Vaginoplasty in Feminizing Genital Surgery; Implementation According to IDEAL Framework
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 25, 2023 (Actual)
Primary Completion Date
December 1, 2024 (Anticipated)
Study Completion Date
March 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Amsterdam UMC, location VUmc

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to assess if a single flap peritoneum vaginoplasty is safe and feasible.The IDEAL framework for evaluation and implementation of surgical techniques will be used. There are two patient groups who are eligible to undergo this procedure. The first group consists of transgender women who either have a shortage of penile skin (so they cannot undergo standard operation technique: penile inversion) or a stenosis of their primary neovagina. The second group consists of women who are born without a vagina or have an acquired short or absent vagina after vaginectomy or hysterectomy because of malignancy of the cervix or vagina. At the moment, standard procedure for both groups in the Amsterdam University Medical Center (UMC) is the sigmoid vaginoplasty, where a part of the bowel is used to form a vaginal cavity. This procedure is risky, because in some cases, the bowel anastomosis is defect. An other more frequent complication, is malodorous excessive discharge. Sometimes accompanied by inflammation of the diversion neovagina. In recent years, the use of the peritoneum vaginoplasty has been described for transgender women. However, the peritoneum is either used as small flaps to deepen the vagina, or the peritoneum is pulled down, which limits the depth of the neovagina. We want to implement a different technique, where the peritoneum is harvested in a single pedicled flap, which is brought down and sutured in the cavity cylinder shaped. The risks are the same as in any laparoscopic surgery, but we suspect the risk of failure of the anastomosis is much lower, as is the chance of a temporary stoma.
Detailed Description
Vaginoplasty is the surgical (re)construction of a neo- vagina. At the moment, the standard procedure to construct a neo-vagina is a penile inversion vaginoplasty. Where the skin of the penis is used as lining of the neovagina. When there is insufficient or no penile skin available, up to now the standard procedure is to form a neovagina through a diversion of the large bowel. This entails extensive colorectal surgery with potential major morbidity. Another complication of this procedure that is more frequent, is malodorous excessive discharge due to colitis of the bowel conduit. Furthermore, ant theoretical risk of malignancy of the diversion vagina is present due to the chronic inflammations. A less morbid peritoneum 'pull down' vaginoplasty is a well-known and widely used alternative technique for cis-women who are born without a vagina. However, the technique limits the maximum achievable depth and subsequent functional outcome. By using a single pedicled peritoneum flap, it is possible to create more depth. In recent years, the peritoneum vaginoplasty is also performed in transgender women, with reported good results. However, in these publications the peritoneum is either used as small flaps to deepen the vagina, or the peritoneum is pulled down. The investigators propose to introduce an optimized technique, based upon a single pedicled peritoneal flap, which is brought down and sutured in the vaginal cavity to form a cylinder. The perioperative risks are suspected to be substantially lower with minimal chance of bowel leakage and thereby the risk on re-interventions or a temporary stoma. Second, at long term the chance of malodorous discharge and chronic inflammation is lower, which is expected to result in improved satisfaction and sexual function. This study aims to assess if the single flap pedicled peritoneum vaginoplasty is safe and feasible in transgender women with penoscrotal hypoplasia or obliteration of the primary neovagina and in cis-women with congenital or acquired lack of vaginal depth.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rokitansky Kuster Hauser Syndrome, Vaginal Neoplasms, Gender Incongruence, Vaginal Obstruction, Penoscrotal Hypoplasia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Single center prospective intervention study
Masking
None (Open Label)
Allocation
N/A
Enrollment
13 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
intervention
Arm Type
Experimental
Arm Description
All participants will undergo a laparoscopic single flap peritoneum vaginoplasty
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic pedicled single flap peritoneum vaginoplasty
Intervention Description
After the perineal part of the operation, in which the vaginal cavity will be dissected, a laparoscopy will be started. During laparoscopy, a single flap peritoneum will be harvested. The flap will be checked for adequate blood supply. The flap will be brought down to the (neo) vaginal cavity and sutured around a dilatator cylinder wise.
Primary Outcome Measure Information:
Title
90 day postoperative complications. Reported by full description of the event and eventual treatment and classified according to Clavien-Dindo classification.
Description
Reported by full description of the event and eventual treatment and classified according to Clavien-Dindo classification.
Time Frame
From start of surgery until 90 days after surgery
Secondary Outcome Measure Information:
Title
Successful technical completion of operation
Description
Postoperative dimension of the neovagina of at least 12 cm, measured by a measuring dilatator.
Time Frame
From start of surgery until 90 days after
Title
Operation time
Description
Learning curve of surgeons
Time Frame
Intraoperative (From start of surgery up until closure of all wounds)
Title
Blood loss
Description
Total estimated blood loss during operation by surgeon in ml
Time Frame
Intraoperative (From start of surgery up until closure of all wounds)
Title
Length of hospital stay
Description
The total amount of days spend in the hospital after operation up until discharge.
Time Frame
From date of operation/intervention until the date of discharge or death, whichever came first, assessed up to 100 days
Title
Sexual function
Description
Sexual function measured by the sexual function form of the genderQ
Time Frame
at 12 months post-operation
Title
Urinary function
Description
Urinary function measured by the urinary function form of the genderQ
Time Frame
at 12 months post-operation
Title
Post-operative pain
Description
Postoperative pain reported by patient either none-normal-or excessive
Time Frame
at 3 weeks, 3 months and 6 months post-operative
Title
Neovaginal dimensions
Description
Postoperative dimension of the neovagina, measured by a measuring dilatator.
Time Frame
at 3 weeks, 3 months and 6 months post-operative
Title
Clitoral sensation
Description
patient assessed outcome, either none- less- normal or hyper
Time Frame
at 3 weeks, 3 months and 6 months post-operative

10. Eligibility

Sex
All
Gender Based
Yes
Gender Eligibility Description
one of two groups consists of transgender or gender diverse individuals, who desire feminizing genital surgery. So they are assigned male at birth, but identify as female or gender diverse.
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Indication for vaginoplasty, with no option to use penoscrotal tissue or with shortage of penoscrotal tissue. Age >18 Able to give informed consent Exclusion Criteria: Contra-indication for laparoscopic surgery Smoking (cessation for at least 6 weeks) BMI 18 < or >30 kg/m2
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marleen Vallinga, MD
Phone
+31204440162
Email
m.s.vallinga@amsterdamumc.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Alessanda Sarsini
Phone
+31204440162
Ext
+31
Email
a.sarsini@amsterdamumc.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mark-Bram Bouman, MD PhD
Organizational Affiliation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Amsterdam University Medical Center
City
Amsterdam
State/Province
Zuid-Holland
ZIP/Postal Code
1081 HV
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marleen S Vallinga, MD
Phone
+31204444444
Email
m.s.vallinga@amsterdamumc.nl
First Name & Middle Initial & Last Name & Degree
Mark-Bram Bouman, MD PhD
Phone
+31 204444444
Email
mark-bram.bouman@amsterdamumc.nl
First Name & Middle Initial & Last Name & Degree
Marleen S Vallinga, MD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28839860
Citation
van der Sluis WB, Bouman M, Meijerink W, Neefjes-Borst EA, van Bodegraven AA. Refractory diversion neovaginitis in a sigmoid-colon-derived neovagina: clinical and histopathological considerations. Frontline Gastroenterol. 2016 Jul;7(3):227-230. doi: 10.1136/flgastro-2015-100602. Epub 2015 Jun 4.
Results Reference
background
PubMed Identifier
26632208
Citation
van der Sluis WB, Bouman MB, Meijerink WJHJ, Elfering L, Mullender MG, de Boer NKH, van Bodegraven AA. Diversion neovaginitis after sigmoid vaginoplasty: endoscopic and clinical characteristics. Fertil Steril. 2016 Mar;105(3):834-839.e1. doi: 10.1016/j.fertnstert.2015.11.013. Epub 2015 Nov 26.
Results Reference
background
PubMed Identifier
27087418
Citation
Qin C, Luo G, Du M, Liao S, Wang C, Xu K, Tang J, Li B, Zhang J, Pan H, Ball TW, Fang Y. The clinical application of laparoscope-assisted peritoneal vaginoplasty for the treatment of congenital absence of vagina. Int J Gynaecol Obstet. 2016 Jun;133(3):320-4. doi: 10.1016/j.ijgo.2015.11.015. Epub 2016 Mar 2.
Results Reference
background
PubMed Identifier
30707129
Citation
Jacoby A, Maliha S, Granieri MA, Cohen O, Dy GW, Bluebond-Langner R, Zhao LC. Robotic Davydov Peritoneal Flap Vaginoplasty for Augmentation of Vaginal Depth in Feminizing Vaginoplasty. J Urol. 2019 Jun;201(6):1171-1176. doi: 10.1097/JU.0000000000000107.
Results Reference
background
PubMed Identifier
34398096
Citation
Jun MS, Gonzalez E, Zhao LC, Bluebond-Langner R. Penile Inversion Vaginoplasty with Robotically Assisted Peritoneal Flaps. Plast Reconstr Surg. 2021 Aug 1;148(2):439-442. doi: 10.1097/PRS.0000000000008198. No abstract available.
Results Reference
background
PubMed Identifier
33776039
Citation
Salibian AA, Schechter LS, Kuzon WM, Bouman MB, van der Sluis WB, Zhao LC, Bluebond-Langner R. Vaginal Canal Reconstruction in Penile Inversion Vaginoplasty with Flaps, Peritoneum, or Skin Grafts: Where Is the Evidence? Plast Reconstr Surg. 2021 Apr 1;147(4):634e-643e. doi: 10.1097/PRS.0000000000007779.
Results Reference
background

Learn more about this trial

Peritoneum Vaginoplasty; Implementation According to IDEAL Framework

We'll reach out to this number within 24 hrs